v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (7,588) $ (5,071)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 60 12
Amortization of debt issuance costs 339 120
Stock-based compensation 990 611
Amortization of right-of-use assets 298 280
Change in fair value of warrant liabilities 291 1,196
Change in fair value of notes payable (220)
Issuances of shares for borrowing related costs 241
Changes in operating assets and liabilities:    
Accounts receivable 86 1,038
Inventory 23 (37)
Prepaid expenses 327 355
Other assets (239) 132
Accounts payable (1,285) (2,049)
Accrued expenses (634) (663)
Deferred revenue (133) (536)
Lease liabilities (360) (276)
Net cash used in operating activities (7,825) (4,867)
Cash flows from financing activities:    
Proceeds from issuance of common stock and warrants 5 3,080
Proceeds from notes payable 6,500 8,260
Payments for notes payable (317) (1,313)
Proceeds from warrant exercises 54
Stock option exercises 180 158
Net cash provided by financing activities 6,422 10,185
Effect of exchange rate changes on cash and cash equivalents (11) 49
Net (decrease) increase in cash and cash equivalents (1,414) 5,367
Cash and cash equivalents, beginning of period 15,394 5,157
Cash and cash equivalents, end of period 13,980 10,524
Supplemental cash flow information:    
Cash paid for interest 587 11
Cash paid for taxes 44 1
Noncash investing and financing activities disclosure:    
Tenant improvement allowance payments made by the lessor directly to a third party (327)
Issuance of common stock to settle notes payable $ 1,192